Outcomes of patients (pts) in ZUMA-9, a multicenter, open-label study of axicabtagene ciloleucel (axi-cel) in relapsed/refractory large B cell lymphoma (R/R LBCL) for expanded access and commercial out-of-specification (OOS) product Meeting Abstract
| Authors: | Jacobson, C. A.; Locke, F. L.; Miklos, D. B.; Vose, J. M.; Lin, Y.; Budde, L. E.; Maloney, D. G.; Jaglowski, S.; Riedell, P. A.; Lekakis, L. J.; Perales, M. A.; Kim, J. J.; Kawashima, J.; Yang, Y.; Rossi, J. M.; Goyal, L.; Neelapu, S. S. |
| Abstract Title: | Outcomes of patients (pts) in ZUMA-9, a multicenter, open-label study of axicabtagene ciloleucel (axi-cel) in relapsed/refractory large B cell lymphoma (R/R LBCL) for expanded access and commercial out-of-specification (OOS) product |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| ACCESSION: | WOS:000607205606004 |
| DOI: | 10.1182/blood-2020-136136 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2 -- Source: Wos |
